Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.

about

Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.Emerging roles for clinical pharmacometrics in cancer precision medicine

P2860

Q55283747-77EE19E8-EB66-4BD5-888A-63D5829F5E7E Q57825305-00A0373F-E0DC-4BB3-BF3B-03C57F195419

P2860

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.

Item

http://www.wikidata.org/entity/Q47616700

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Optimization of rituximab for ...... ose for elderly male patients.

@en

Optimization of rituximab for ...... ose for elderly male patients.

@nl

type

Item

label

Optimization of rituximab for ...... ose for elderly male patients.

@en

Optimization of rituximab for ...... ose for elderly male patients.

@nl

prefLabel

Optimization of rituximab for ...... ose for elderly male patients.

@en

Optimization of rituximab for ...... ose for elderly male patients.

@nl

P1476

Optimization of rituximab for ...... dose for elderly male patients

@en

P2093

Ali-Nuri Hünerlitürkoglu

http://www.w3.org/2001/XMLSchema#string

Carsten Zwick

http://www.w3.org/2001/XMLSchema#string

Christian Berdel

http://www.w3.org/2001/XMLSchema#string

Christian Rübe

http://www.w3.org/2001/XMLSchema#string

Gerhard Held

http://www.w3.org/2001/XMLSchema#string

Judith Dierlamm

http://www.w3.org/2001/XMLSchema#string

Lorenz Truemper

http://www.w3.org/2001/XMLSchema#string

M Loeffler

http://www.w3.org/2001/XMLSchema#string

Marita Ziepert

http://www.w3.org/2001/XMLSchema#string

Martin Dreyling

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.

Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma

Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.

P304

410-420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14860

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Michael Pfreundschuh

Ulrich Keller

P577

2017-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28990173

http://www.w3.org/2001/XMLSchema#string

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.

about

P2860

P2860

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698